using ZBH 145c expired in Aug to trade it into its next earning
According to Argus,
ZBH completed an inverse headand-shoulders bottom in mid-Aprilon above-average volume.
On May 2, the stock gapped higher to recovery highs on massive volumefollowing better-than-expected quarterly results. The gap did not hold and over the next four weeks, the shares pulled all the way back
to their 21-month exponential. ZBH then popped back quickly and now is approaching its early May highs.
If the slightly damaged inverse H&S works out, we could see a measured move to $160 or higher, which is not far from the April 2021 all-time high at $170.
Medical device stocks have been in favor since late 2022.
ZBH completed an inverse headand-shoulders bottom in mid-Aprilon above-average volume.
On May 2, the stock gapped higher to recovery highs on massive volumefollowing better-than-expected quarterly results. The gap did not hold and over the next four weeks, the shares pulled all the way back
to their 21-month exponential. ZBH then popped back quickly and now is approaching its early May highs.
If the slightly damaged inverse H&S works out, we could see a measured move to $160 or higher, which is not far from the April 2021 all-time high at $170.
Medical device stocks have been in favor since late 2022.